- Home
- WIW vs ANGO Comparison
WIW vs ANGO Comparison
Compare WIW & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WIW | ANGO |
|---|---|---|
| Founded | 2004 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.9M | 400.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | WIW | ANGO |
|---|---|---|
| Price | $8.68 | $13.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 229.9K | ★ 430.9K |
| Earning Date | 01-01-0001 | 01-07-2026 |
| Dividend Yield | ★ 11.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $8.01 | $8.27 |
| 52 Week High | $9.37 | $13.99 |
Technical Indicators
Market Signals| Indicator | WIW | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 39.10 | 58.82 |
| Support Level | $8.67 | $13.12 |
| Resistance Level | $8.73 | $13.53 |
| Average True Range (ATR) | 0.07 | 0.43 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 61.80 |
Price Performance
Historical ComparisonAbout WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.